Actionable news
All posts from Actionable news
Actionable news in NVLS: NOVELLUS SYSTEM ORD,

Nivalis Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Nivalis Therapeutics, Inc. NVLS, +0.00% a clinical stage pharmaceutical company focused on treating people with cystic fibrosis ("CF"), today announced the grant to Dr. David Rodman, the Company's newly appointed chief medical officer and executive vice president of discovery, of a non-statutory stock option to purchase an aggregate of 108,333 shares of its common stock and of restricted stock units representing 216,667 shares of its common stock. The inducement grants were approved by Nivalis' Compensation Committee and were made as an inducement material to Dr. Rodman's acceptance of employment with the Company in accordance with NASDAQ Listing Rule 5635(c)(4).

The stock option has an exercise price equal to $4.68, which was the closing price of Nivalis' common stock on April 18...